Stock ACXP ACURX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Acurx Pharmaceuticals, Inc.

Equities

ACXP

US00510M1045

Delayed Nasdaq
Other stock markets
 12:14:35 2024-05-17 pm EDT 		5-day change 1st Jan Change
2.225 USD +3.00% Intraday chart for Acurx Pharmaceuticals, Inc. +9.60% -41.91%
May. 15 Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection CI
May. 15 Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024
cc259fc98.yBycFsgFsBr0xZErIPyc4c-e54YFRyYNEeevnrXdLeg.jHXpd71mwG2f8NNPbabxuantq_c0HxBcQ6ru2oytXaOGc-9a-n_1e6es3A~21a404973865c3c6a89a147aa0797179
  1. Stock Market
  2. Equities
  3. ACXP Stock
  4. Charts Acurx Pharmaceuticals, Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW